DJ-1 as a Therapeutic Target Against Cancer

Adv Exp Med Biol. 2017:1037:203-222. doi: 10.1007/978-981-10-6583-5_13.

Abstract

DJ-1 is a gene involved in various cellular processes, including transcriptional regulation, oxidative stress response, fertilization, mitochondrial regulation, inflammatory and fibrogenic niche formation, and glycation damage prevention. Although a disease-associated genetic study within the past decade has demonstrated that the mutation of DJ-1 is associated with autosomal early-onset Parkinson's disease, increasing evidence suggests that DJ-1 also plays a critical role in tumor development and progression. In this review, we provide an overview of current knowledge concerning the role and the mechanism of DJ-1 in cancer and also discuss the possibility of DJ-1 as a therapeutic target against cancer.

Keywords: Cancer therapeutics; DJ-1; Mechanism; Oncogene; Target.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • Disease Progression
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Models, Genetic
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / metabolism
  • Oncogene Proteins / genetics*
  • Oncogene Proteins / metabolism
  • Protein Deglycase DJ-1 / antagonists & inhibitors
  • Protein Deglycase DJ-1 / genetics*
  • Protein Deglycase DJ-1 / metabolism
  • RNA Interference

Substances

  • Biomarkers, Tumor
  • Oncogene Proteins
  • Protein Deglycase DJ-1